Tsuchimoto Kim R

CIK 00013335164 companiesNOVATO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001333516

Recent Transactions

50 trades

Award
Monopar Therapeutics$MNPR
Stock Options
2025-12-02+2,924→ 2,924 total
Exercise of In-Money
Monopar Therapeutics$MNPR
Stock Options
2025-07-14−4,200→ 0 total
Exercise of In-Money
Monopar Therapeutics$MNPR
Stock Options
2025-07-14−4,704→ 0 total
Exercise of In-Money
Monopar Therapeutics$MNPR
Common Stock
2025-07-14$0.01/sh+8,904→ 20,390 total
Sale
Monopar Therapeutics$MNPR
Common Stock
2025-07-14$40.00/sh−8,904→ 11,486 total
Award
Monopar Therapeutics$MNPR
Stock Options
2025-03-04+11,365→ 11,365 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2024-06-30+9,957→ 60,427 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2024-06-30$0.73/sh−2,998→ 57,429 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2024-06-30−9,957→ 74,412 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2024-03-31+9,956→ 54,552 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2024-03-31−9,956→ 84,369 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2024-03-31$0.68/sh−4,082→ 50,470 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2024-01-01−1,231→ 94,325 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2024-01-01$0.34/sh−505→ 44,596 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2024-01-01+1,231→ 45,101 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-12-31−9,957→ 95,556 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-12-31+9,957→ 47,943 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2023-12-31$0.34/sh−4,073→ 43,870 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-09-30+9,956→ 41,430 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-09-30−9,956→ 105,513 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2023-09-30$0.62/sh−3,444→ 37,986 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2023-06-30$0.85/sh−5,104→ 31,474 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-06-30−14,846→ 115,469 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-06-30+14,846→ 36,578 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2023-03-31$1.39/sh−1,842→ 21,732 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-03-31−5,067→ 130,315 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-03-31+5,067→ 23,574 total
Award
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-02-01+78,234→ 135,382 total
Award
Monopar Therapeutics$MNPR
Stock Options
2023-02-01+102,688→ 102,688 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-01-01+1,230→ 19,009 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-01-01−1,230→ 1,231 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2023-01-01$2.37/sh−502→ 18,507 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2022-12-31$2.37/sh−2,067→ 17,779 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2022-12-31−5,067→ 55,917 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2022-12-31+5,067→ 19,846 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2022-09-30−5,066→ 63,445 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2022-09-30+5,066→ 16,532 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2022-09-30$1.52/sh−1,753→ 14,779 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2022-06-30−8,913→ 68,511 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2022-06-30+8,913→ 14,549 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2022-06-30$2.30/sh−3,083→ 11,466 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2022-03-31$2.55/sh−500→ 5,636 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2022-03-31+1,221→ 6,136 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2022-03-31−1,221→ 77,424 total
Award
Monopar Therapeutics$MNPR
Stock Options
2022-02-02+81,395→ 81,395 total
Award
Monopar Therapeutics$MNPR
Restricted Stock Units
2022-02-02+61,532→ 78,645 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2022-01-01$3.21/sh−505→ 4,915 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2022-01-01−1,231→ 2,461 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2022-01-01+1,231→ 5,420 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2021-12-31+1,221→ 4,690 total

Companies

Recent Filings

Address

C/O RAPTOR PHARMACEUTICAL CORP. 9 COMMERCIAL BLVD., SUITE 200

NOVATO, CA, 94949

View on SEC.gov